📰 Upstream Bio News
Page 2 - Upstream Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Upstream Bio. Real-time updates on events, politics, business and more.
March 2, 2023
/PRNewswire/ -- DelveInsights Asthma Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline asthma...
March 2, 2023
Asthma is a chronic disease that affects a substantial number of patients worldwide, including children, a number of pharmaceutical companies are involved in developing drugs for asthma. This
January 4, 2023
/PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for the industrys most promising up-and-coming...
August 9, 2022
Upstream Bio has initiated a phase 1b study of UPB-101 in asthma patients with the dosing of the first patient.
July 5, 2022
In addition to recent Independence Day festivities, the U.S. biotech space has other reasons to celebrate. The asthma drug developer Upstream Bio topped the ranks for the U.S.’ biggest early-stage biotech investment in June 2022, but manufacturing heavyweight National Resilience, Inc. bagged the private funding top spot with a huge Series D round.
June 2, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 5, 2022
More than 500 people are expected to attend the weekend-long event that will bring together global experts, public policy leaders, students, faculty, and alumni for weekend of provocative discussions, a new facility dedication, and community celebrations, all focused on innovation, collaboration, and the art of the possible.
January 21, 2022
HBM Healthcare Investments AG / Key word(s): Quarter Results HBM Healthcare Investments Quarterly Report December 2021 21-Jan-2022 / 06:46 CE...